The exploratory study for the efficacy and the safety of rikkunshito on symptoms of upper gastrointestinal tract in the patients with gastroesophageal reflux disease (GERD)

Not Applicable

• Conditions: GERD patients

• Registration Number: JPRN-UMIN000003092
• Lead Sponsor: Chiba University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-01-26
• Study Completion: 2010-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with severe cardiac failure, acute inflammatory disease or other severe complications 2) Patients who are pregnant, considering pregnancy or lactation 3) Patients with serious disorder in liver, gallbladder, or pancreas 4) Patients with gastrectomy 5) Patients who are intolerant to oral administration 6) Patients who received drugs prohibited for concomitant use during the observation period 7) Patients during treatment by traditional Japanese medicines 8) Patients considered inappropriate by the study investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of upper gastrointestinal symptoms in GERD patients

Secondary Outcome Measures

Name	Time	Method
1)Improvement of function of esophageal motility 2)Safety of rikkunshito